Several studies have shown that NHE3 deficiency predispose patients and animals to microbial dysbiosis and IBD (Engevik et al., 2013; Larmonier et al., 2013; Janecke et al., 2016; Laubitz et al., 2016; Harrison et al., 2018). Here, SLC9A3 is linked to inflammatory bowel disease.